The work builds on recent progress in Alzheimer’s treatment, specifically in amyloid-targeting drugs for individuals with mild cognitive impairment or early-stage Alzheimer’s. The new study seeks to take this a step further by testing whether intervention at an earlier stage can potentially prevent symptoms altogether. https://longevity.technology/news/new-alzheimers-study-targets-disease-decades-before-symptoms-occur/